Literature DB >> 30093162

Mortality due to immunotherapy related hepatitis.

Prachi Bhave1, Andrew Buckle2, Shahneen Sandhu1, Siddharth Sood3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30093162     DOI： 10.1016/j.jhep.2018.06.012

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  6 in total

1.  Hepatobiliary and Pancreatic Adverse Events.

Authors:  Hao Chi Zhang; Lan Sun Wang; Ethan Miller
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Immune-Mediated Hepatitis During Immune Checkpoint Inhibitor cancer Immunotherapy: Lessons From Autoimmune Hepatitis and Liver Immunology.

Authors:  Julian Hercun; Catherine Vincent; Marc Bilodeau; Pascal Lapierre
Journal:  Front Immunol       Date:  2022-06-30       Impact factor: 8.786

Review 3.  The Role of Myeloid Cells in Hepatotoxicity Related to Cancer Immunotherapy.

Authors:  Cathrin L C Gudd; Lucia A Possamai
Journal:  Cancers (Basel)       Date:  2022-04-10       Impact factor: 6.575

4.  Checkpoint inhibitor-induced hepatotoxicity: Role of liver biopsy and management approach.

Authors:  Fernando Bessone; Einar Stefan Bjornsson
Journal:  World J Hepatol       Date:  2022-07-27

5.  Efficacy of artificial liver support system in severe immune-associated hepatitis caused by camrelizumab: A case report and review of the literature.

Authors:  You-Wen Tan; Li Chen; Xing-Bei Zhou
Journal:  World J Clin Cases       Date:  2021-06-16       Impact factor: 1.337

Review 6.  When steroids are not enough in immune-related hepatitis: current clinical challenges discussed on the basis of a case report.

Authors:  Dimitrios C Ziogas; Aikaterini Gkoufa; Evangelos Cholongitas; Panagiotis Diamantopoulos; Amalia Anastasopoulou; Paolo Antonio Ascierto; Helen Gogas
Journal:  J Immunother Cancer       Date:  2020-11       Impact factor: 13.751
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.